Dr. Rich Gliklich
XIR, CEO & Chairman of OM1
As an XIR, Dr. Rich Gliklich leverages his operational experience and domain expertise to support businesses in the healthcare and life sciences industries.
Previously, Rich was President of the Outcome division of Quintiles, the largest provider of biopharmaceutical development and commercial outsourcing services, and he also served on its Executive Committee through its 2013 IPO. Prior to Quintiles, Rich was Founder, CEO and Chairman of Outcome, a health information and services company that served more than 2500 healthcare organizations and a majority of the global top 30 life sciences companies. Rich led Outcome from its start as a spin-off from his Harvard affiliated research laboratory in 1998 through its acquisition by Quintiles in October 2011.
In addition to his experience as an entrepreneur and executive, Dr. Gliklich is well known in the areas of outcomes and analytics. He is senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook “Registries for Evaluating Patient Outcomes: A User’s Guide” and has led several key national and international efforts focused on evaluating the safety, effectiveness, value and quality of healthcare. Some of the programs developed with Dr. Gliklich include the American Heart Association’s Get With The GuidelinesSM registries which received the 2004 Innovation Award from the U.S. Department of Health and Human Services and the 2007 eHealth Initiative Award. Rich also holds several patents for both health outcomes systems and medical devices.
Rich is a graduate of Yale University and Harvard Medical School and a former Charles A. Dana Scholar at the University of Pennsylvania. In addition to his work with General Catalyst, Rich is also a surgeon and a chaired Professor at Harvard Medical School.